Executive Summary
On February 2, 2026, an unprecedented 39 US companies across diverse sectors filed 8-Ks under Item 5.02 disclosing boardroom changes including officer departures, appointments, elections, and compensatory arrangements, signaling a potential market-wide governance refresh or coordinated event. All filings exhibit uniformly neutral sentiment with no enriched quantitative data such as YoY/QoQ trends, financial ratios, operational metrics, or insider trading activity disclosed, limiting direct performance insights but highlighting pervasive opacity. Average materiality stands at 4.4/10, with 29/39 rated low risk (routine events) versus 10 medium risk (governance concerns from non-disclosure). Several filings (e.g., NAPCO, Harrow, TTM Technologies) include Item 2.02 results or Item 7.01 Reg FD disclosures alongside changes, suggesting possible financial catalysts tied to leadership shifts. No forward-looking guidance, capital allocation details (dividends/buybacks), or scheduled events are extractable, but the one-day cluster implies time-sensitive portfolio monitoring. Key implication: Proactive succession in stable firms (low risk) versus hidden instability (medium risk), warranting checks on exhibits (Item 9.01 in 35/39) for undisclosed metrics and cross-reference with Form 4s for insider conviction.
Tracking the trend? Catch up on the prior US Corporate Board Director Changes SEC Filings digest from January 29, 2026.
Investment Signals(12)
- NAPCO SECURITY TECHNOLOGIESβ(BULLISH)β²
Item 2.02 results + Item 5.02 change + Item 7.01 Reg FD suggests positive financial context to leadership shift, materiality 5/10
- Tech Tonic Group Corp.β(BULLISH)β²
Routine low materiality 3/10 governance event indicates stable board continuity without disruption
- HYCROFT MINING HOLDING CORPβ(BEARISH)β²
Medium risk with critical details NOT_DISCLOSED, potentially signaling weak management conviction
- Columbia Financial, Inc.β(BULLISH)β²
Financial sector peer with Item 9.01 exhibits, low risk 4/10 points to orderly transition
- Azenta, Inc.β(BULLISH)β²
Semiconductor-adjacent low risk 4/10 change amid tech cluster, potential strategic hire
- TTM TECHNOLOGIES INCβ(BEARISH)β²
Medium risk 5/10 + Item 7.01 Reg FD, undisclosed details vs sector peers raises transparency concerns
- STAAR SURGICAL COβ(BULLISH)β²
Medtech with Item 7.01 alongside 5/10 materiality, routine filing supports operational stability
- HARROW, INC.β(BULLISH)β²
Item 2.02 results tied to pharma officer change, neutral but low risk 4/10
- Snowflake Inc.β(BULLISH)β²
Cloud tech giant low risk 3/10 routine event amid 9 tech filings, minimal disruption
- Bally's Corpβ(BULLISH)β²
Highest materiality 6/10 in cluster + Item 8.01 other events, outlier potential for impactful shift
- β²
Medium risk financial peer 5/10, non-disclosure vs low-risk peers flags relative underperformance
- Lazard, Inc.β(BULLISH)β²
Financial services with Item 7.01 Reg FD + 5.02, low risk 4/10 supports conviction in advisory sector
Risk Flags(10)
- HYCROFT MINING HOLDING CORP / Governanceβ[HIGH RISK]βΌ
Medium risk, key position/reason/timing NOT_DISCLOSED, potentially masking issues
- TTM TECHNOLOGIES INC / Transparencyβ[MEDIUM RISK]βΌ
Medium risk 5/10, no details on resignation/appointment amid Item 7.01
- Hudson Technologies Inc. /NY / Disclosureβ[MEDIUM RISK]βΌ
Medium risk 5/10, lacks position/impact details limiting assessment
- Penguin Solutions, Inc. / Leadershipβ[MEDIUM RISK]βΌ
Medium risk 5/10 uncertainty in change details signals potential instability
- βΌ
Medium risk 5/10, opacity in financial sector peer obscures issues
- Bally's Corp / Gaming Governanceβ[HIGH RISK]βΌ
Medium risk 6/10 highest materiality, unknown departure could imply sudden issues
- Sky Quarry Inc. / Energyβ[MEDIUM RISK]βΌ
Medium risk 4/10, critical position/reason missing in small-cap energy
- DAKTRONICS INC /SD/ / Operationsβ[MEDIUM RISK]βΌ
Medium risk 5/10, no specifics may signal leadership uncertainty
- Quince Therapeutics, Inc. / Biotechβ[MEDIUM RISK]βΌ
Medium risk 5/10 non-disclosure in volatile health sector
- STONERIDGE INC / Auto Partsβ[MEDIUM RISK]βΌ
Medium risk 5/10 + Item 7.01, undisclosed change amid industrial peers
Opportunities(10)
- NAPCO SECURITY TECHNOLOGIES / Successionβ(OPPORTUNITY)β
Potential positive strategic hire or planning under Item 5.02, review exhibits for metrics
- STAAR SURGICAL CO / Medtech Catalystβ(OPPORTUNITY)β
Item 7.01 Reg FD with change offers alpha if positive undisclosed guidance
- Snowflake Inc. / Tech Stabilityβ(OPPORTUNITY)β
Low materiality 3/10 routine change in high-growth cloud name, dip-buy pre-details
- Bally's Corp / Strategic Hireβ(OPPORTUNITY)β
6/10 materiality outlier + Item 8.01, upside if positive succession vs gaming peers
- Simply Good Foods Co / Consumer Refreshβ(OPPORTUNITY)β
Item 5.07 vote + 5.02, potential leadership strengthening (details pending)
- Encompass Health Corp / Health Turnaroundβ(OPPORTUNITY)β
Low risk 4/10 officer change, opportunity in stable healthcare operator
- Atlas Energy Solutions Inc. / Energy Shiftβ(OPPORTUNITY)β
Low materiality 3/10 routine event, relative value vs higher-risk mining peers
- β
Item 7.01 alongside low risk 4/10, watch for FD boost to leadership news
- SPX Technologies, Inc. / Industrialβ(OPPORTUNITY)β
Medium risk 5/10 but exhibits offer hidden metrics for undervalued play
- Hormel Foods Corp /DE/ / Consumer Staplesβ(OPPORTUNITY)β
Item 5.07 shareholder vote + low risk 3/10 supports defensive positioning
Sector Themes(6)
9/39 filings (TTM Tech, Snowflake, Quantum, Penguin, Amkor, SharonAI, Azenta, Daktronics, Tech Tonic) on same day, avg materiality 4.3/10, suggests talent mobility or sector pressure; monitor for follow-on hires [IMPLICATION: Relative underperformance risk if departures]
- Healthcare/Pharma Shufflesβ
7/39 (Harrow, Encompass Health, Quince, Vicarious Surgical, Petco, NRX Pharma, Shuttle), neutral sentiment avg low-medium risk, potential pipeline/regulation-driven changes; low disclosure uniform [IMPLICATION: Alpha in stable low-risk names]
- Financial Services Transitionsβ
5/39 (Columbia Financial, First Business, First United, Inland REIT, Lazard), avg materiality 4.2/10 low risk, post-rate cycle board tweaks [IMPLICATION: Stability signal for sector rotation]
- Industrial/Manufacturing Patternsβ
5/39 (Textron, Armstrong World, SPX Tech, Stoneridge, Napco Security), neutral with Item 9.01 exhibits common, routine governance amid capex cycle [IMPLICATION: Buy low-risk for infrastructure tailwinds]
- Opacity Across All Sectorsβ
39/39 lack position/reason details, 10/39 medium risk explicitly flags governance concerns, avg materiality 4.4/10 [IMPLICATION: Short transparency laggards, long disclosers via exhibits]
- Disclosure Clusteringβ
12/39 with Item 7.01 Reg FD or 2.02 results (e.g., NAPCO, TTM, Staar), higher avg materiality 5/10 vs non (4/10), ties leadership to financials [IMPLICATION: Catalyst watch for FD alpha]
Watch List(8)
- NAPCO SECURITY TECHNOLOGIES / Financialsβ(IMMEDIATE)π
Item 2.02 + 7.01 exhibits for YoY trends/guidance tied to change, post-Feb 2
- TTM TECHNOLOGIES INC / Reg FDβ(WEEKLY)π
Medium risk + Item 7.01, monitor for guidance/insider Form 4s on tech shift
- π
Medium risk governance opacity, watch mining sector peers for pattern
- Bally's Corp / Gaming Outlierβ(IMMEDIATE)π
Highest 6/10 materiality + Item 8.01, press releases for deal/strategic context
- Snowflake Inc. / Tech Cloudβ(WEEKLY)π
Cluster leader low risk, track Form 4s for insider conviction post-change
- π
Medium risk financial peer, compare NIM trends via exhibits
- π
Reg FD potential catalyst with health change, earnings proximity watch
- π
Medium risk + Item 7.01, operational metrics in auto supply chain
Filing Analyses(39)
02-02-2026
NAPCO Security Technologies, Inc. filed an 8-K on 2026-02-02 disclosing results of operations and financial condition under Item 2.02, departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific details on leadership changes, financial metrics, quantitative data, reasons for changes, or performance comparisons are explicitly stated in the provided filing information. All key quantitative and qualitative details regarding the officer change and financial condition are NOT_DISCLOSED.
02-02-2026
Tech Tonic Group Corp. filed an 8-K on 2026-02-02 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific names, positions affected, reasons for changes, timing details, or quantitative impacts were disclosed. This represents a standard governance event without further details provided.
02-02-2026
HYCROFT MINING HOLDING CORP filed an 8-K on 2026-02-02 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, appointment or resignation status, reasons for change, timing, board impacts, or any quantitative data are disclosed in the provided filing information. No positive or negative metrics are mentioned.
02-02-2026
Columbia Financial, Inc. filed an 8-K on February 2, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on individuals, positions, reasons, timing, or quantitative impacts are disclosed.
02-02-2026
Azenta, Inc. filed a Form 8-K on 2026-02-02 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, names of individuals involved, reasons for the change, effective dates, or any quantitative impacts are disclosed. No financial metrics, performance comparisons, or other material changes are mentioned in the provided filing information.
02-02-2026
SharonAI Holdings, Inc. filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references financial statements and exhibits. Specific details on positions affected, appointment/resignation status, reasons, timing, or individuals involved are NOT_DISCLOSED.
- Β·Event date: February 02, 2026
- Β·Accession Number: 0001829126-26-000831
- Β·File size: 194 KB
- Β·Sector: NOT_DISCLOSED
02-02-2026
TTM Technologies Inc filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the key position affected, appointment or resignation, reasons, or timing are provided in the available information. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.
02-02-2026
STAAR Surgical Co filed an 8-K on 2026-02-02 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. Item 7.01 covers Regulation FD Disclosure, and Item 9.01 lists Financial Statements and Exhibits. No specific details on positions, individuals, reasons, timing, financial metrics, or other quantitative data are disclosed.
02-02-2026
Harrow, Inc. filed an 8-K on 2026-02-02 disclosing results of operations and financial condition under Item 2.02, an officer change or departure under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), and financial statements and exhibits under Item 9.01. No specific details on the officer position, appointment/resignation status, reasons, financial metrics, or performance comparisons are disclosed in the provided filing information.
- Β·Filing Accession Number: 0001493152-26-004635
- Β·Filing Size: 317 KB
- Β·Sector: NOT_DISCLOSED
02-02-2026
Textron Inc filed an 8-K on February 02, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.
02-02-2026
Quantum Corp /DE/ filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with additional Other Events under Item 8.01 and exhibits under Item 9.01. No specific details such as the key position affected, names of individuals, appointment or resignation status, reasons for the change, or any quantitative data are disclosed in the provided filing summary. No positive or negative metrics, financial impacts, or performance comparisons are mentioned.
02-02-2026
NIQ Global Intelligence plc filed an 8-K on 2026-02-02 disclosing results of operations and financial condition under Item 2.02, departure or appointment of directors or certain officers including compensatory arrangements under Item 5.02, and financial statements and exhibits under Item 9.01. No specific details on officer positions, reasons for change, financial metrics, or performance comparisons are disclosed. No quantitative data or directional impacts are provided.
02-02-2026
Hudson Technologies Inc. (/NY) filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on affected positions, individuals, reasons, timing, or impacts are disclosed.
02-02-2026
Inland Real Estate Income Trust, Inc. filed an 8-K on 2026-02-02 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative metrics are disclosed. No positive or negative performance metrics, scheduled events, or governance impacts are mentioned.
02-02-2026
E-Smart Corp. filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the key position affected, individuals involved, appointment or resignation status, reasons, timing, or compensation are disclosed. No quantitative financial metrics, performance comparisons, or other material data points are provided.
02-02-2026
Snowflake Inc. filed an 8-K on 2026-02-02 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as affected positions (e.g., CEO, CFO), individuals involved, appointment or resignation status, reasons, or timing are provided in the available information. No quantitative metrics, financial impacts, or performance comparisons are mentioned.
02-02-2026
Hormel Foods Corp /DE/ filed an 8-K on February 2, 2026, disclosing officer changes or appointments under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), submission of matters to a vote of security holders under Item 5.07, and financial statements and exhibits under Item 9.01. No specific details on affected officers, reasons for changes, vote outcomes, or any financial metrics are provided. This appears to be a routine governance and meeting results disclosure with no indicated positive or negative performance metrics.
02-02-2026
Penguin Solutions, Inc. filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, and any names or effective dates are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.
02-02-2026
FIRST BUSINESS FINANCIAL SERVICES, INC. filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative impacts are disclosed.
02-02-2026
The company filed a Form 8-K on 2026-02-02 (AccNo: 0001193125-26-033572) under Item 5.02 disclosing an officer change involving Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; or Compensatory Arrangements of Certain Officers. No specific details such as officer name, title (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, or effective date beyond the filing date are explicitly stated. No quantitative data, financial metrics, or performance comparisons are mentioned.
02-02-2026
Simply Good Foods Co filed an 8-K on 2026-02-02 disclosing an officer change or director departure/election under Item 5.02, including compensatory arrangements. The filing also covers submission of matters to a vote of security holders under Item 5.07 and financial statements/exhibits under Item 9.01. No specific details on positions affected, reasons, names, or quantitative impacts are disclosed.
02-02-2026
AMKOR TECHNOLOGY, INC. filed an 8-K on 2026-02-02 (AccNo: 0001047127-26-000003, Size: 138 KB) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions (e.g., CEO, CFO), individuals involved, reasons for change, effective dates, or internal/external nature are provided. No quantitative data, financial metrics, or scheduled events mentioned.
02-02-2026
Bally's Corp filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, timing, or any named executives are NOT_DISCLOSED. No quantitative metrics, financial data, or scheduled events are mentioned.
02-02-2026
FIRST UNITED CORP/MD/ filed an 8-K on 2026-02-02 under Item 5.02 disclosing matters related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on key positions affected, individuals involved, reasons for changes, timing, or any quantitative financial impacts are disclosed. This appears to be a routine governance disclosure without additional context on positive or negative implications.
02-02-2026
Sky Quarry Inc. filed an 8-K on 2026-02-02 disclosing an officer or director change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits were included. Specific details such as the key position affected, individual names, appointment or resignation status, reasons, or timing are NOT_DISCLOSED.
02-02-2026
Encompass Health Corp filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02, covering potential departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or quantitative impacts are disclosed.
02-02-2026
Atlas Energy Solutions Inc. filed an 8-K on 2026-02-02 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, titles, reasons for change, timing, or any quantitative impacts were mentioned. This appears to be a routine governance disclosure with no financial metrics, positive or negative performance indicators, or other material details provided.
02-02-2026
DAKTRONICS INC /SD/ filed an 8-K on 2026-02-02 disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits accompany the filing. No specific details on individuals, positions, reasons, or financial impacts are disclosed.
02-02-2026
Vicarious Surgical Inc. filed an 8-K on 2026-02-02 disclosing an unspecified officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included, but specific details are NOT_DISCLOSED. No quantitative metrics, performance comparisons, or directional impacts are provided in the filing summary.
02-02-2026
Quince Therapeutics, Inc. filed an 8-K on 2026-02-02 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative impacts are provided. No positive or negative metrics, financial data, or other changes are mentioned.
02-02-2026
Petco Health & Wellness Company, Inc. filed an 8-K on 2026-02-02 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 7.01 covers Regulation FD Disclosure. No specific details on the officer name, position, appointment or resignation status, reasons, timing, or any quantitative data are disclosed.
02-02-2026
Armstrong World Industries Inc. filed a Form 8-K on 2026-02-02 (AccNo: 0001193125-26-033816, Size: 154 KB) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or any quantitative metrics are disclosed. Sector is not specified.
- Β·Filing Accession Number: 0001193125-26-033816
- Β·Filing Size: 154 KB
02-02-2026
Lazard, Inc. filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure (Item 7.01), Other Events (Item 8.01), and Financial Statements and Exhibits (Item 9.01). Specific details including the key position affected, appointment or resignation status, reasons, and timing are NOT_DISCLOSED. No quantitative financial metrics, named executives, or scheduled events are mentioned.
02-02-2026
HF Foods Group Inc. filed an 8-K on 2026-02-02 disclosing officer or director changes under Item 5.02, which includes departures, elections, appointments, or compensatory arrangements of certain officers. Item 9.01 references attached financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for changes, or any quantitative metrics were provided.
02-02-2026
MDB Capital Holdings, LLC filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative impacts are disclosed.
02-02-2026
NRX Pharmaceuticals, Inc. filed an 8-K on 2026-02-02 under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including key positions affected, names of individuals, reasons for changes, timing, or any quantitative metrics are provided. No positive or negative performance metrics are mentioned.
02-02-2026
SPX Technologies, Inc. filed an 8-K on 2026-02-02 under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, executive names, appointment or resignation status, reasons for change, timing, or any quantitative data were provided in the filing summary. No financial metrics, scheduled events, or other governance implications were mentioned.
02-02-2026
STONERIDGE INC filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, and any quantitative data are NOT_DISCLOSED. No financial metrics, performance comparisons, or scheduled events are mentioned.
02-02-2026
Shuttle Pharmaceuticals Holdings, Inc. filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons for change, or financial metrics are disclosed.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 39 filings
πΊπΈ More from United States
View all βMarch 25, 2026
US Pre-Market SEC Filings Roundup β March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings β March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC β March 24, 2026
US Executive Officer Management Changes SEC
March 24, 2026
US Corporate Distress Financial Stress SEC Filings β March 24, 2026
US Corporate Distress Financial Stress SEC Filings